
TFMB-(R)-2-HG
CAS No. 1445700-01-5
TFMB-(R)-2-HG ( —— )
产品货号. M23608 CAS No. 1445700-01-5
TFMB-(R)-2-HG 是急性髓系白血病 (AML) 的致癌因子。 TFMB-(R)-2-HG 响应雌激素撤退而损害 SCF ER-Hoxb8 细胞分化。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥794 | 有现货 |
![]() ![]() |
5MG | ¥1369 | 有现货 |
![]() ![]() |
10MG | ¥2130 | 有现货 |
![]() ![]() |
25MG | ¥3969 | 有现货 |
![]() ![]() |
50MG | ¥5856 | 有现货 |
![]() ![]() |
100MG | ¥7995 | 有现货 |
![]() ![]() |
500MG | ¥16038 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称TFMB-(R)-2-HG
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TFMB-(R)-2-HG 是急性髓系白血病 (AML) 的致癌因子。 TFMB-(R)-2-HG 响应雌激素撤退而损害 SCF ER-Hoxb8 细胞分化。
-
产品描述TFMB-(R)-2-HG is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cell differentiation in response to estrogen withdrawal.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Carcinogenic factor
-
研究领域——
-
适应症——
化学信息
-
CAS Number1445700-01-5
-
分子量288.22
-
分子式C13H11F3O4
-
纯度>98% (HPLC)
-
溶解度DMSO:240 mg/mL (832.7 mM)
-
SMILESO=C([C@@H](CC1)OC1=O)OCC2=CC=CC(C(F)(F)F)=C2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Losman JA, et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science. 2013 Mar 29;339(6127):1621-5.
产品手册




关联产品
-
5,6,7,3',4'-Pentamet...
5,6,7,3',4'-pentamethoxyflavanone exhibited anti-proliferative activities.
-
Dimethylethylcarbino...
一种支链戊醇,主要用作化合物或颜料溶剂。
-
C-Reactive Protein (...
CRP, an acute phase serum protein synthesized in response to inflammatory cytokines, produces antitumor effects in animals. The fragment CRP (174-185) (RS-83277) shows similar activity by significantly enhancing the tumoricidal activity of human monocytes and alveolar macrophages in vitro.